Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty-Reference-Cited by-同舟云学术

Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty

Published:2013-08-01 Issue:6 Volume:82 Page:869-877
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Dudek Dariusz¹,Mehran Roxana²,Dziewierz Artur¹,Witzenbichler Bernhard³,Brodie Bruce R.⁴,Kornowski Ran⁵,Fahy Martin²,Lansky Alexandra J.⁶,Rakowski Tomasz¹,Legutko Jacek¹,Bryniarski Leszek¹,Stone Gregg W.²

Affiliation:

1. Department of Interventional Cardiology; Jagiellonian University Medical College; Krakow Poland

2. Columbia University Medical Center and the Cardiovascular Research Foundation; New York

3. Charite University Medicine Campus Benjamin Franklin; Berlin Germany

4. LeBauer Cardiovascular Research Foundation/Moses Cone Hospital; Greensboro North Carolina

5. Cardiology Department; Rabin Medical Center; Petach Tikva Israel

6. Yale University School of Medicine; New Haven Connecticut

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.24813/fullpdf

Reference25 articles.

1. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study;Daemen;Lancet,2007

2. The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use;Hoffmann;Clin Res Cardiol,2009

3. A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: The DERIVATION score;Capodanno;Clin Res Cardiol,2009

4. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction;Stone;N Engl J Med,2009

5. Sirolimus-eluting versus uncoated stents in acute myocardial infarction;Spaulding;N Engl J Med,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction;Texas Heart Institute Journal;2024-05-01

2. Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials;Cardiovascular Revascularization Medicine;2019-09

3. Impact of stent generation on 2‐year clinical outcomes in ST‐segment elevation myocardial infarction patients with multivessel disease who underwent culprit‐only or multivessel percutaneous coronary intervention;Catheterization and Cardiovascular Interventions;2019-08-18

4. A comparison of the impact of current smoking on 2-year major clinical outcomes of first- and second-generation drug-eluting stents in acute myocardial infarction;Medicine;2019-03

5. Five-year major clinical outcomes between first-generation and second-generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention;J GERIATR CARDIOL;2018